Immunome, Inc. (IMNM)
19.84
-0.46
(-2.27%)
USD |
NASDAQ |
Dec 11, 13:37
Immunome Market Cap: 1.820B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precision BioSciences, Inc. | 66.68M |
| CEL-SCI Corp. | 20.42M |
| AIM ImmunoTech, Inc. | 1.146M |
| IGC Pharma, Inc. | 29.91M |
| NovaBay Pharmaceuticals, Inc. | 352.20M |
Market Cap Related Metrics
| PS Ratio | 162.49 |
| Price to Book Value | 6.894 |
| Price | 19.84 |
| Earnings Yield | -14.90% |